Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization URGN - UroGen Pharma Ltd.
1.7 M
LAST VALUE
-1.94%
2 YEAR CAGR
32.53%
5 YEAR CAGR
57.63%
10 YEAR CAGR